gusperimus + glucocorticoids

Gusperimus + glucocorticoids is a combination therapy consisting of gusperimus, an immunosuppressive agent, and glucocorticoids, a class of corticosteroid hormones. Gusperimus (also known as 15-deoxyspergualin) acts by modulating immune responses through effects on various arms of the immune system, including inhibition of lymphocyte proliferation and function[1][2][6]. Glucocorticoids exert broad anti-inflammatory and immunosuppressive effects primarily via binding to the glucocorticoid receptor, leading to suppression of pro-inflammatory gene expression. This combination has been investigated for use in autoimmune diseases such as granulomatosis with polyangiitis (Wegener's granulomatosis), where it aims to induce remission while reducing long-term exposure to more toxic agents like cyclophosphamide[2][5][8].